LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection

被引:4
作者
Zhang, Chunhui [1 ]
Yang, Rui [1 ]
Wang, Xinxin [2 ]
Tao, Yuqing [1 ]
Tang, Shuli [3 ]
Tian, Zhennan [4 ]
Zhou, Yang [2 ]
机构
[1] Harbin Med Univ Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ Canc Hosp, Dept Pathol, Harbin, Heilongjiang, Peoples R China
关键词
Hepatocellular carcinoma; Magnetic resonance imaging; Morphological classification; Prediction; Prognosis; MACROSCOPIC CLASSIFICATION; INTRAHEPATIC RECURRENCE; RISK-FACTORS; PHASE;
D O I
10.1245/s10434-023-13494-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThis study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after radical surgery of hepatocellular carcinoma (HCC).Patients and MethodsA retrospective analysis of 296 patients with HCC who underwent radical resection was performed. On the basis of LI-RADS, tumor imaging morphology was classified into three types. The clinical imaging features, ER, and survival rates of three types were compared. Univariate and multivariate Cox regression analyses were conducted to identify prognostic factors associated with OS and ER after hepatectomy for HCC.ResultsThere were 167 tumors of type 1, 95 of type 2, and 34 of type 3. In patients with type 3 HCC, postoperative mortality and ER were significantly higher than in patients with type 1 and type 2 (55.9% versus 32.6% versus 27.5% and 52.9% versus 33.7% versus 28.7%). In multivariate analysis, the LI-RADS morphological type was a stronger risk factor for predicting poor OS [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.59-4.85, P < 0.001] and ER (HR 2.14, 95% CI 1.24-3.70, P = 0.007). A subgroup analysis revealed that type 3 was associated with poor OS and ER in > 5 cm cases but not in < 5 cm cases.ConclusionsER and OS of patients with HCC undergoing radical surgery can be predicted using the preoperative tumor LI-RADS morphological type, which could help to select personalized treatment plans for patients with HCC in the future.
引用
收藏
页码:4876 / 4885
页数:10
相关论文
共 50 条
  • [21] Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy
    Razek, A. A. K. Abdel
    El-Serougy, L. G.
    Saleh, G. A.
    Shabana, W.
    Abd El-Wahab, R.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (09) : 547 - 553
  • [22] Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS
    Choi, Se Jin
    Choi, Sang Hyun
    Kim, Dong Wook
    Byun, Jae Ho
    Won, Hyung Jin
    Shin, Yong Moon
    JOURNAL OF HEPATOLOGY, 2023, 78 (03) : 596 - 603
  • [23] Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
    Cunha, Guilherme Moura
    Chernyak, Victoria
    Fowler, Kathryn J.
    Sirlin, Claude B.
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 513 - 527
  • [24] Prognostic implications of CT/MRI LI-RADS in hepatocellular carcinoma: State of the art and future directions
    Wei, Hong
    Yang, Ting
    Chen, Jie
    Duan, Ting
    Jiang, Hanyu
    Song, Bin
    LIVER INTERNATIONAL, 2022, 42 (10) : 2131 - 2144
  • [25] LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid–enhanced MRI for early recurrence risk stratification after curative resection
    Hong Wei
    Hanyu Jiang
    Tianying Zheng
    Zhen Zhang
    Caiwei Yang
    Zheng Ye
    Ting Duan
    Bin Song
    European Radiology, 2021, 31 : 2289 - 2302
  • [26] Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: A retrospective study
    Kawano, Y.
    Sasaki, A.
    Kai, S.
    Endo, Y.
    Iwaki, K.
    Uchida, H.
    Shibata, K.
    Ohta, M.
    Kitano, S.
    EJSO, 2009, 35 (02): : 174 - 179
  • [27] Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
    Sugimoto, Katsutoshi
    Kamiyama, Naohisa
    Kakegawa, Tatsuya
    Takahashi, Hiroshi
    Wada, Takuya
    Abe, Masakazu
    Yoshimasu, Yu
    Takeuchi, Hirohito
    Itoi, Takao
    ULTRASONOGRAPHY, 2023, 42 (03) : 388 - 399
  • [28] Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System
    Sun, Yajuan
    Yu, Can
    Wang, Xinxin
    Yang, Rui
    Ding, Zhipeng
    Zhou, Yang
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (12) : 2787 - 2796
  • [29] Surgical Resection vs. Percutaneous Ablation for Single Hepatocellular Carcinoma: Exploring the Impact of Li-RADS Classification on Oncological Outcomes
    Centonze, Leonardo
    Di Sandro, Stefano
    Lauterio, Andrea
    De Carlis, Riccardo
    Frassoni, Samuele
    Rampoldi, Antonio
    Tuscano, Bruno
    Bagnardi, Vincenzo
    Vanzulli, Angelo
    De Carlis, Luciano
    CANCERS, 2021, 13 (07)
  • [30] Gadoxetic acid-enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
    Wang, Ruizhi
    Xu, Hengtian
    Chen, Wufei
    Jin, Liang
    Ma, Zhuangxuan
    Wen, Lei
    Wang, Hongwei
    Cao, Kun
    Du, Xia
    Li, Ming
    FRONTIERS IN ONCOLOGY, 2023, 13